Boldine: A potential new antiproliferative drug against glioma cell lines

Investigational New Drugs

Volumn 27, Issue 6, 2009, Pages 517-525

  Gerhardt, Daniéli ^a   Horn, Ana Paula ^a   Gaelzer, Mariana Maier ^a   Frozza, Rudimar Luiz ^a   Delgado Cañedo, Andrés ^b   Pelegrini, Alessandra Luiza ^a   Henriques, Amélia T ^a   Lenz, Guido ^a   Salbego, Christianne ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b INSTITUTO DE CARDIOLOGIA DO RIO GRANDE DO SUL   (Brazil)

Author keywords

Anti tumor agent; Boldine; Glioma; Proliferation

Indexed keywords

( 2,9 DIHYDROXY 1,10 DIMETHOXY APORPHINE); ANTINEOPLASTIC AGENT; APORPHINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL DEATH; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GLIOMA; HUMAN; HUMAN CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; APORPHINES; BRAIN; BRAIN NEOPLASMS; CASPASE 3; CASPASE 9; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; DNA DAMAGE; DRUG SCREENING ASSAYS, ANTITUMOR; G2 PHASE CELL CYCLE CHECKPOINTS; GLIOMA; HUMANS; MALE; MITOSIS; RATS; RATS, WISTAR;

EID: 70450273511     PISSN: 01676997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10637-008-9203-7     Document Type: Article

References (35)

1. NG Aygeropoulos TT Batchelor 1999 New treatment strategies for malignant gliomas Oncologist 4 209 224
2. FG Davis BJ McCarthy S Freels 1999 The conditional probability of survival of patients with primary malignant brain tumors: surveillance, epidemiology, and end results (SEER) data Cancer 85 85 491 10.1002/(SICI)1097- 0142(19990101)85:1<85::AID-CNCR12>3.0.CO;2-A (Pubitemid 29031360)
3. EA Maher FB Furnari RM Bachoo, et al. 2001 Malignant glioma: genetics and biology of a grave matter Genes Dev 15 1311 1333 10.1101/gad.891601 1:CAS:528:DC%2BD3MXktlSntbw%3D 11390353 (Pubitemid 32524640)
4. M Weller A Fontana 1995 The failure of current immunotherapy for malignant glioma. Tumor-derived TGF-beta, T-cell apoptosis, and the immune privilege of the brain Brain Res Brain Res Rev 21 128 151 10.1016/0165-0173(95) 00010-0 1:STN:280:DyaK2s%2FitVartA%3D%3D 8866671 (Pubitemid 26060933)
5. D Trog M Fountoulakis A Friedlein, et al. 2006 Is current therapy of malignant gliomas beneficial for patients? Proteomics evidence of shifts in glioma cells expression patterns under clinically relevant treatment conditions Proteomics 6 2924 2930 10.1002/pmic.200500587 1:CAS:528:DC%2BD28XltF2itb0%3D 16596702 (Pubitemid 43752052)
6. JD Phillipson 2001 Phytochemistry and medicinal plants Phytochemistry 56 237 243 10.1016/S0031-9422(00)00456-8 1:CAS:528:DC%2BD3MXpslOgsg%3D%3D 11243450 (Pubitemid 32162796)
7. DJ Newman GM Cragg KM Snader 2003 Natural products as sources of new drugs over the period 1981-2002 J Nat Prod 66 1022 1037 10.1021/np030096l 1:CAS:528:DC%2BD3sXksVylu7g%3D 12880330 (Pubitemid 36909859)
8. C Stévigny C Bailly J Quetin-Leclercq 2005 Cytotoxic and antitumour potentialities of aporphinoid alkaloids Curr Med Chem Anti-Canc Agents 5 173 182 10.2174/1568011053174864 (Pubitemid 40347990)
9. ME Hidalgo M Farah L Carrasco, et al. 2005 Photostability and photoprotection factor of boldine and glaucine J Photochem Photobiol B 80 65 69 10.1016/j.jphotobiol.2005.01.005 1:CAS:528:DC%2BD2MXlt1Wgs74%3D 15963438 (Pubitemid 40823840)
10. H Speisky BK Cassels E Lissi, et al. 1991 Antioxidant properties of the alkaloid boldine in systems undergoing lipid peroxidation and enzyme inactivation Biochem Pharmacol 41 1575 1581 10.1016/0006-2952(91)90156-Y 1:CAS:528:DyaK3MXkt1aiuro%3D 2043147
11. J Martínez L Ríos M Payá, et al. 1992 Inhibition of non-enzymic lipid peroxidation by benzylisoquinoline alkaloids Free Radic Biol Med 12 287 292 10.1016/0891-5849(92)90116-X 1577331
12. A Cederbaum E Kikielka H Speisky 1992 Inhibition of rat liver microsomal lipid peroxidation by boldine Biochem Pharmacol 44 1765 1772 10.1016/0006-2952(92)90070-Y 1:CAS:528:DyaK3sXntlKitA%3D%3D 1333206
13. MC Lanhers M Joyeux R Soulimani, et al. 1991 Hepatoprotective and anti-inflammatory effects of a traditional medicinal plant of Chile, Peumus boldus Planta Med 57 110 115 10.1055/s-2006-960043 1:STN:280: DyaK3MzmslyrtQ%3D%3D 1891491
14. S Hoet C Stévigny S Block, et al. 2004 Alkaloids from Cassytha filiformis and related aporphines: antitrypanosomal activity, cytotoxicity, and interaction with DNA and topoisomerases Planta Med 70 407 413 10.1055/s-2004-818967 1:CAS:528:DC%2BD2cXktlOkurw%3D 15124084 (Pubitemid 38716472)
15. P Skehan R Storeng D Scudiero, et al. 1990 New colorimetric cytotoxicity assay for anti-cancer-drug screening J Natl Cancer Inst 82 1107 1112 10.1093/jnci/82.13.1107 1:CAS:528:DyaK3cXltVylsL8%3D 2359136
16. A Bernardi MC Jacques-Silva A Delgado-Cañedo, et al. 2006 Nonsteroidal anti-inflamatory drugs inhibit the growth of C6 and U138-MG glioma cell lines Eur J Pharmacol 532 214 222 10.1016/j.ejphar.2006.01.008 1:CAS:528:DC%2BD28XhvVWls7Y%3D 16487511 (Pubitemid 43295497)
17. WR Overton JP McCoy Jr 1994 Reversing the effect of formalin on the binding of propidium iodide to DNA Cytometry 16 351 356 10.1002/cyto.990160410 1:CAS:528:DyaK2cXmt1Gntr4%3D 7527317 (Pubitemid 24246403)
18. L Stoppini PA Buchs D Muller 1991 A simple method for organotypic cultures of nervous tissue J Neurosci Methods 37 173 182 10.1016/0165-0270(91) 90128-M 1:STN:280:DyaK3MzltVymtA%3D%3D 1715499
19. LM Valentim R Rodnight AB Geyer 2003 Changes in heat shock protein 27 phosphorylation and immunocontent in response to preconditioning to oxygen and glucose deprivation in organotypic hippocampal cultures Neuroscience 118 379 386 10.1016/S0306-4522(02)00919-3 1:CAS:528:DC%2BD3sXivV2gsbk%3D 12699774 (Pubitemid 36423253)
20. AP Horn D Gerhardt AB Geyer 2005 Cellular death in hippocampus in response to PI3-K pathway inhibition and oxygen and glucose deprivation Neurochem Res 30 355 361 10.1007/s11064-005-2609-0 1:CAS:528: DC%2BD2MXksl2gsLk%3D 16018579 (Pubitemid 40880811)
21. H Tsuiki M Nitta M Tada 2001 Mechanism of hyperploid cell formation induced by microtubule inhibiting drug in glioma cell lines Oncogene 20 420 429 10.1038/sj.onc.1204126 1:CAS:528:DC%2BD3MXhsVKjtL8%3D 11313973 (Pubitemid 32158222)
22. A Hartmann G Speit 1997 The contribution of cytotoxicity to DNA-effects in the single cell gel test (comet assay) Toxicol Lett 90 183 188 10.1016/S0378-4274(96)03847-7 1:CAS:528:DyaK2sXhtFSgtbw%3D 9067486 (Pubitemid 27096533)
23. AR Collins 2004 The comet assay for DNA damage and repair: principles, applications, and limitations Mol Biotechnol 26 249 261 10.1385/MB:26:3:249 1:CAS:528:DC%2BD2cXivF2gu7c%3D 15004294 (Pubitemid 41490465)
24. W Zhang Z Fei H Zhen, et al. 2007 Resveratrol inhibits cell growth and induces apoptosis of rat C6 glioma cells J Neurooncol 81 231 240 10.1007/s11060-006-9226-x 1:CAS:528:DC%2BD2sXktFWht7Y%3D 17031560 (Pubitemid 46165325)
25. X Liu J Wang B Sun, et al. 2007 Cell growth inhibition, G2M cell cycle arrest, and apoptosis induced by the novel compound Alternol in human gastric carcinoma cell line MGC803 Invest New Drugs 25 505 517 10.1007/s10637-007-9057-4 17619824
26. MJ Van den Bent ME Hegi R Stupp 2006 Recent developments in the use of chemotherapy in brain tumours Eur J Cancer 42 582 588 10.1016/j.ejca.2005.06.031 16427778 (Pubitemid 43343679)
27. G Kroemer B Dallaporta M Resche-Rigon 1998 The mitochondrial death/life regulator in apoptosis and necrosis Annu Rev Physiol 60 619 642 10.1146/annurev.physiol.60.1.619 1:CAS:528:DyaK1cXitVOhsbs%3D 9558479 (Pubitemid 28157889)
28. DO Morgan 1995 Principles of cdk regulation Nature 374 131 134 10.1038/374131a0 1:CAS:528:DyaK2MXkt1yju7s%3D 7877684
29. PB Dirks JT Rutka 1997 Current concepts in neuro-oncology: the cell cycle-a review Neurosurgery 40 1000 1013 10.1097/00006123-199705000-00025 1:STN:280:DyaK2s3ptlartA%3D%3D 9149259
30. W Fiers R Beyaert W Declercq, et al. 1999 More than one way to die: apoptosis, necrosis and reactive oxygen damage Oncogene 18 7719 7730 10.1038/sj.onc.1203249 1:CAS:528:DC%2BD3cXlt1WgsA%3D%3D 10618712
31. C Borner L Monney 1999 Apoptosis without caspases: an inefficient molecular guillotine? Cell Death Differ 6 497 507 10.1038/sj.cdd.4400525 1:CAS:528:DyaK1MXktlCjsbc%3D 10381652
32. T Mochizuki A Asai N Saito, et al. 2002 Akt protein kinase inhibits non-apoptotic programmed cell death induced by ceramide J Biol Chem 277 2790 2797 10.1074/jbc.M106361200 1:CAS:528:DC%2BD38XhtVSgtrs%3D 11706021 (Pubitemid 34953310)
33. MO Hengartner 2000 The biochemistry of apoptosis Nature 407 770 776 10.1038/35037710 1:CAS:528:DC%2BD3cXnsFWrsLc%3D 11048727 (Pubitemid 30780739)
34. S Chandna 2004 Single-cell gel electrophoresis assay monitors precise kinetics of DNA fragmentation induced during programmed cell death Cytometry A 61 127 133 10.1002/cyto.a.20071 15382149 (Pubitemid 39362287)
35. D Trog H Moenkemann W Breipohl, et al. 2007 Non-sufficient cell cycle control as possible clue for the resistance of human malignant glioma cells to clinically relevant treatment conditions Amino Acids 32 373 379 10.1007/s00726-006-0456-1 1:CAS:528:DC%2BD2sXjvFamsrY%3D 17077962 (Pubitemid 46559586)